Loading...
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
The American Heart Association has updated its 2008 guidelines on detecting and managing resistant hypertension — defined as above-goal blood pressure (≥130/80 mm Hg) despite use of three antihypertensive drugs, or controlled BP on a four-drug regimen.
The guidelines, published in Hypertension, contain numerous practical diagnostic and clinical management tips. Among the most notable:
Healthcare providers should regularly ask patients with resistant hypertension about their sleep patterns. Poor sleep duration and quality trigger the sympathetic and renin-angiotensin systems and, thus, can interfere with BP control.
The role of lifestyle is emphasized as part of first-line management of resistant hypertension. Clinicians should advise patients to follow a low-sodium diet (<2400 mg/daily), lose excess weight, exercise, and get at least 6 hours of uninterrupted sleep each night.
If BP is above goal despite an optimal lifestyle and adherence to a three-drug regimen, providers should consider switching from hydrochlorothiazide to chlorthalidone or indapamide. If BP is still high after that, spironolactone may be considered as a fourth drug.
Comment
LINK(S):
AHA guideline in Hypertension (Free)
Background: NEJM Journal Watch Cardiology coverage of spironolactone vs. clonidine in resistant hypertension (Your NEJM Journal Watch subscription required)